Health Care Businesses

Health care software firm RealMed regains momentum

January 2, 2010
Peter Schnitzler
RealMed enjoys a nearly 99-percent renewal rate among its current customers and attracted 4,000 new doctors in 2009. Employment at the company is rising after a steady decline.
More

Corporations bet on insiders to bend reform

December 30, 2009
J.K. Wall
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional leaders and committees in health reform process.
More

Health care industry braces for reform

December 26, 2009
J.K. Wall
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity late in the year.
More

To keep sales force busy, Lilly takes on new drug

December 24, 2009
J.K. Wall
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel to push.
More

First Indiana Future Fund off to a slow startRestricted Content

December 19, 2009
Peter Schnitzler
More than half of the venture capital fund's original investors took a pass on its $58 million successor, the newly launched INext.
More

Setbacks in diabetes market batter Roche

December 19, 2009
J.K. Wall
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And it’s mulling whether to keep fighting on all fronts or to pull back.
More

Senate rejects drug-importation proposal

December 16, 2009
 IBJ Staff and Associated Press
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers such as Indianapolis-based Eli Lilly and Co. a victory.
More

Lilly wins approval for long-acting Zyprexa

December 14, 2009
J.K. Wall
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
More

Eli Lilly's shares slip after it forecasts mixed profits in coming years

December 10, 2009
 IBJ Staff and Associated Press
The Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results could fall precipitously.
More

Lilly launching new venture capital fund

December 10, 2009
J.K. Wall
The fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly's drug pipeline.
More

Company's medical device earns expedited review

December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing techniques could begin as early as next year, with commercialization following by 2012.
More

Ariad asks court to restore patent-suit win against Lilly

December 8, 2009
 IBJ Staff
A federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent claim.
More

Part of Mississippi's Zyprexa case against Lilly dismissed

December 2, 2009
 IBJ Staff
Indianapolis-based Eli Lilly and Co. has won a bid to dismiss part of a negligence lawsuit brought by Mississippi that alleges improper marketing of antipsychotic drug Zyprexa for unapproved uses.
More

Lilly extends research pact with India firm

December 1, 2009
 IBJ Staff
Jubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five years.
More

Lilly's Cymbalta wins new approval for anxiety disorder

November 30, 2009
J.K. Wall
FDA action should boost sales of the Eli Lilly and Co. drug, which were already on pace to top $3 billion this year.
More

Lilly stock droops after rival claims faster-acting impotence pill

November 18, 2009
 IBJ Staff
California-based Vivus claims its drug acts in 30 minutes, compared with about 2 hours for Lilly's Cialis.
More

Arcadia sees bigger quarterly loss on lower revenue

November 16, 2009
J.K. Wall
Health care company Arcadia Resources Inc. saw growth in pharmacy business, offset by slower medical staffing sales.
More

Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters

November 14, 2009
 IBJ Staff
Thanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided locating here would give Aarden a better chance of success.
More

Hill-Rom's fourth quarter profit exceeds expectations

November 12, 2009
 IBJ Staff
The Batesville-based maker of hospital equipment reported profit of $26.4 million, or 42 cents per share, in the period ended Sept. 30.
More

Lilly to pay Utah $24 million to settle Zyprexa suit

November 11, 2009
Eli Lilly and Co. has agreed to pay Utah $24 million to settle a lawsuit claiming the company improperly marketed the antipsychotic drug Zyprexa.
More

Arcadia adds Goldsmith to board, seeks $11M in offering

November 9, 2009
J.K. Wall
Indianapolis-based Arcadia Resources Inc. has added former Indianapolis Mayor Steve Goldsmith to its board and plans to raise $11.1 million in a registered direct stock offering.
More

Struggling Bioanalytical Systems adds outsider to boardRestricted Content

November 7, 2009
Peter Schnitzler
Shareholders are starting to make inroads in their effort to turn struggling West Lafayette-based Bioanalytical Systems Inc. in a new direction.
More

UPDATE: Life science firm to add 100 jobs at Park 100

November 6, 2009
 IBJ Staff
California-based life science firm Beckman Coulter Inc. is moving its precision plastics injection molding operation to the Park 100 business park on Indianapolis' northwest side, making what it calls a multimillion-dollar investment in the operation.
More

TechPoint to focus on IT firms specializing in medical, life sciences sectorsRestricted Content

October 31, 2009
Chris O'Malley
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
More

Doctors balk at Senate attempt to cut out wasteful health care spending

October 31, 2009
 IBJ Staff
The big goal of health care reform is to cut wasteful spending to pay for expanded health insurance coverage. But the way the Senate Finance Committee bill tries to do that would be, according to some doctors, “disastrous.”
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT